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data of investigators from urology departments participating in the study
every year. Each center entered inpatient data on a single day in the study
periods. The point prevalence data on nosocomial urinary tract infection was
used to find differences among Asian geographic regions.
A total of 659 patients, 436 males (66.2 %) and 223 (33.8 %) females, were
diagnosed with urinary tract infection during the study period. Mean age was
54.9  19.3. Cystitis and pyelonephritis were the most frequent clinical
diagnoses representing 18.4 and 15.0 % respectively. Echerichia coli was
found to be the most frequent uropathogen (171 of 659 isolates) (25.9 %).
Cephalosporins were preferred in 34.4 % of cases followed by fluoroquino-
lones (24.1 %), aminoglycosides (16.8 %), penicillins (7.1 %) and carbapenems
(6.5 %). Resistance rates of fluoroquinolones against proven bacterium were
relatively high (ciprofloxacin 54.9%, levofloxacin 39.0%). Resistance rates of
cephalosporins were more than 42% (42.5w 54.7%). Amikacin and imipenem
were maintaining universal resistant patterns (24.9% and 11.3% respec-
tively). Resistance to almost pathogens was lowest in Middle East Asia.
The resistance rates of most of the uropathogens against the antibiotics
tested show variation by region in Asia. Almost Asian countries have high
resistance rate in broad-spectrum antibiotics inevitably as increasing
antibiotic usage. Knowledge of regional and local resistance data and
prudent use of antibiotics are necessary to optimize antibiotic therapy in
urological patients with NAUTI.SP 9-3
PREVENTION AND CONTROL OF CATHETER ASSOCIATED URINARY TRACT
INFECTION
Paul Anantharajah Tambyah. Department of Medicine, National University
of Singapore, Singapore
Catheter associated Urinary Tract infections are the most common nosoco-
mial infections worldwide. While they are associated with morbidity and
mortality especially when urinary tract obstruction occurs, more impor-
tantly, they are a major reservoir for antimicrobial resistant pathogens.
Several approaches have been attempted to prevent and control CAUTI.
These have been driven by a scientific understanding of the pathogenesis of
the disease but have been hampered by the inability to deal with the biofilm
which develops rapidly once the catheter has been inserted. There has been
a renewed interest in biomaterials but the best material which can prevent
CAUTI in clinical situations has yet to be found. In the interim, the most
successful approaches have been those focusing on process measures
including a number of reminder systems which ensure closed drainage and
reduced duration of catheterization.SYMPOSIUM 10 (SP 10)
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STREPTOCOCCUS PNEUMONIAE
David Greenberg, MD. The Pediatric Infectious Disease Unit, Soroka
University Medical Center, Faculty of Health Sciences, Ben-Gurion
University of the Negev, Beer-Sheva, Israel
The impact of the pneumococcal 7-valent conjugated vaccine (PCV7) on
reduction of invasive pneumococcal disease (IPD) community-acquired
pneumonia (CAP) and acute otitis media (AOM) in children <5 years old
has been reported in various studies. These reductions varied in different
parts of the world, partially due to different endpoints definitions. IPD cases
of the serotypes included in PCV7 declined by more than 90% in the United
States. However, in other countries the reduction was only moderate. A
significant reduction in the number of primary care visits and hospitaliza-
tions due to CAP has been reported from the US. Antibiotic resistant S. pneu-
moniae strains were reported to have decreased significantly in IPD. In
addition, antibiotic use for AOM has dropped significantly.
In countries which introduced the extended 13-valent conjugated vaccine
(PCV13) into the national immunization programs an additional significant
reduction in all pneumococcal related diseases such as IPD were demon-
strated. Moreover, dramatic reductions of 50 to 72% in CAP rates wereobserved after the introduction of PCV13. AOM cases declined significantly
by 60% and pneumococcal AOM by almost 80% with the near elimination of
serotypes included in the PCV13. Indirect protection of the PCVs was also
observed through significant reduction of IPD cases in person >65 years of
age. Finally, significant reduction rates in antibiotic resistant S. pneumoniae
were observed after PCV13 introduction.
As a consequence of PCV13 introduction and its impact, treatment
recommendations for pneumococcal related diseases have been changed
due to reduction in the prevalence of these diseases as well as the reduction
in antibiotic resistance rates.SP 10-2
IMMUNIZATION ACROSS THE LIFESPAN: ADULT VACCINATIONS
Melvin A. Kohn, MD, MSCE . Merck, United States
The world’s population is ageing with life expectancy increasing in most
countries globally. Estimated life expectancy at birth in 2014 in Taiwan is
approximately 80 years. Taiwan’s NDC projects that the percentage of people
> 65will increase fromw12.5% in 2015 tow40.6%, withmedian age increasing
fromw40 years tow58.6 years. An ageing societywill require its population to
remain healthy longer to decrease the burden of illness and remain in the
workforce to maintain self-sufficiency. As a result, preventing disease has
become a higher priority for governments and the public. This includes
reducing the burden of illness due to infectious diseases through immuniza-
tions. Increasingly, governments and healthcare providers have recognized
the importance of immunizations in preventing diseases such as influenza,
pneumococcal disease, herpes zoster, pertussis and others that have a higher
incidence as people age and their natural immunity wanes. Policy makers are
recommending vaccines in the adult population and adding coverage to their
National Immunization Programs. In addition, to expand vaccination opportu-
nities, vaccine providers in many countries now include other health profes-
sionals, such as pharmacists, who are licensed to vaccinate eligible adults.
As well, some countries have adult immunization practice standards that
apply to all healthcare providers, both vaccinators and non-vaccinators.
This presentation will review new developments in the policies and practice
of immunizations targeting the adult population.SP 10-3
TRANSMISSION, OUTCOMES AND VACCINE DEVELOPMENT OF
ENTEROVIRUS 71
Luan-Yin Chang, MD, PhD. Division of Pediatric Infectious Diseases,
Department of Pediatrics, National Taiwan University Hospital, College of
Medicine, National Taiwan University, Taiwan
Enterovirus 71 was first isolated from cases with encephalitis and meningitis in
l969 inCalifornia,USA. Thereafter, several small sporadicoutbreaks occurred in
American, Europe, Japan and Australia. Large epidemic outbreaks with high
mortality rates occurred: in Bulgaria in 1975 with 44 deaths, in Hungary in 1978
with 47 deaths, inMalaysia in 1997with at least 31 deaths, and inTaiwan in 1998
with 78 deaths, recently also in mainland China where hundreds of fatal cases
were found each year and also in Vietnam.
The enterovirus 71 (EV71) outbreak in Taiwan in 1998 is very well-known to
have caused a lot of HFMD, 405 severe and 78 fatal children cases. There
were a lot of questions about this outbreak. Dr. Lu did the seroepidemiology
before and after the 1998 EV71 epidemic in Taipei City, the seroconversion
rate was estimated to be about 10% in young children. Estimation of the
infected children <6 years: 180,000, so severe case rate: 2.2/1000 and
fatality rate: 0.44/1000, about one in two thousand. Among a cohort of 81
children, Lu et al found that the annual EV71 seroconversion rates (3 to 4%)
between 1994 and 1997 were significantly lower than the rate (7 to 11%)
before 1994. It is likely that there was lower incidence of EV71 infection
between 1994 and 1997 and accumulation of susceptible hosts over the
threshold density might have triggered the 1998 outbreak.
From seroepidemiological study, we found the most important places for
children EV71 transmission to be households and daycare centers/kindergar-
tens. We did a prospective family cohort study of EV71 household trans-
mission. The overall enterovirus 71 transmission rate of household contacts
was 52% (176/339): 84% (70/83) for siblings, 83% (19/23) for cousins, 41% (72/
175) for parents, 28% (10/36) for grandparents and 26% (5/19) for uncles/
aunts. Among 87 infected adults, 53% (46/87) were asymptomatic, 39% (34/
